anisodamine has been researched along with ST Elevated Myocardial Infarction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, M; Niu, X; Peng, Y; Sun, S; Zhang, J; Zhang, Z | 1 |
Fan, WZ; Fan, YM; Fu, XH; Fu, Y; Gu, XS; Hao, GZ; Jiang, YF; Li, YJ; Wei, QM | 1 |
Bai, S; Bi, X; Fan, Y; Fu, X; Gu, X; Li, W; Wang, Y; Wei, L | 1 |
1 review(s) available for anisodamine and ST Elevated Myocardial Infarction
Article | Year |
---|---|
Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Topics: Aged; Bayes Theorem; Coronary Circulation; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Odds Ratio; Percutaneous Coronary Intervention; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents | 2018 |
2 trial(s) available for anisodamine and ST Elevated Myocardial Infarction
Article | Year |
---|---|
Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
Topics: Aged; Cardiac Catheterization; China; Coronary Circulation; Coronary Thrombosis; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Microcirculation; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Thrombectomy; Thrombolytic Therapy; Time Factors; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency | 2019 |
Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.
Topics: Aged; Cardiovascular Agents; China; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Stents; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2016 |